Veracyte, Inc. today announced that Phillip G. Febbo, M.D., will join the company on October 2 as chief scientific officer and chief medical officer. Dr. Febbo, a distinguished industry and academic.
Illumina (NASDAQ:ILMN – Get Rating) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share guidance of $4.00-$4.20 for the period, compared to the consensus earnings per share estimate of $4.15. The company issued revenue guidance of $5.16 billion-$5.25 billion, compared to the consensus revenue estimate of $5.23 billion. A number […]
Illumina (NASDAQ:ILMN – Get Rating) had its price objective dropped by equities research analysts at Piper Sandler from $460.00 to $360.00 in a research report issued on Sunday, The Fly reports. Piper Sandler’s price target indicates a potential upside of 54.14% from the company’s current price. Several other equities research analysts have also issued reports […]
Illumina (NASDAQ:ILMN – Get Rating) updated its FY 2022 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $4.00-$4.20 for the period, compared to the consensus estimate of $4.15. The company issued revenue guidance of $5.16 billion-$5.25 billion, compared to the consensus revenue estimate of $5.23 billion. A number of brokerages […]
Illumina (NASDAQ:ILMN – Get Rating) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share guidance of $4.00-$4.20 for the period, compared to the consensus earnings per share estimate of $4.15. The company issued revenue guidance of $5.16 billion-$5.25 billion, compared to the consensus revenue estimate of […]